NLRP3 inflammasome in sepsis (Review)
- Authors:
- Xueyan Shi
- Sichuang Tan
- Sipin Tan
-
Affiliations: Department of Sepsis Translational Medicine, Key Laboratory of Hunan Province, Xiangya School of Medicine, Central South University, Changsha, Hunan 410008, P.R. China, Department of Thoracic Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China - Published online on: May 13, 2021 https://doi.org/10.3892/mmr.2021.12153
- Article Number: 514
This article is mentioned in:
Abstract
 |
|
Kim M and Li G: Postoperative complications affecting survival after cardiac arrest in general surgery patients. Anesth Analg. 126:858–864. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, et al: Global, regional, and national sepsis incidence and mortality, 1990–2017: Analysis for the Global Burden of Disease Study. Lancet. 395:200–211. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Davis FM, Schaller MA, Dendekker A, Joshi AD, Kimball AS, Evanoff H, Wilke C, Obi AT, Melvin WJ, Cavassani K, et al: Sepsis Induces Prolonged Epigenetic Modifications in Bone Marrow and Peripheral Macrophages Impairing Inflammation and Wound Healing. Arterioscler Thromb Vasc Biol. 39:2353–2366. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xu S, Zhou Z, Li H, Liu Z, Pan X, Wang F, Huang Y, Li X, Xiao Y, Pan J, et al: BMSCs ameliorate septic coagulopathy by suppressing inflammation in cecal ligation and puncture-induced sepsis. J Cell Sci. 131:1312018.PubMed/NCBI | |
|
Gruda MC, Ruggeberg KG, O'Sullivan P, Guliashvili T, Scheirer AR, Golobish TD, Capponi VJ and Chan PP: Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. PLoS One. 13:e01916762018. View Article : Google Scholar : PubMed/NCBI | |
|
Salomão R, Ferreira BL, Salomão MC, Santos SS, Azevedo LCP and Brunialti MKC: Sepsis: Evolving concepts and challenges. Braz J Med Biol Res. 52:e85952019. View Article : Google Scholar | |
|
Lv X and Wang H: Pathophysiology of sepsis-induced myocardial dysfunction. Mil Med Res. 3:302016.PubMed/NCBI | |
|
Nieman GF, Andrews P, Satalin J, Wilcox K, Kollisch-Singule M, Madden M, Aiash H, Blair SJ, Gatto LA and Habashi NM: Acute lung injury: How to stabilize a broken lung. Crit Care. 22:1362018. View Article : Google Scholar : PubMed/NCBI | |
|
Strate LL and Morris AM: Epidemiology, pathophysiology, and treatment of diverticulitis. Gastroenterology. 156:1282–1298.e1. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zarbock A, Gomez H and Kellum JA: Sepsis-induced acute kidney injury revisited: Pathophysiology, prevention and future therapies. Curr Opin Crit Care. 20:588–595. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Varatharaj A and Galea I: The blood-brain barrier in systemic inflammation. Brain Behav Immun. 60:1–12. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Abderrazak A, Syrovets T, Couchie D, El Hadri K, Friguet B, Simmet T and Rouis M: NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol. 4:296–307. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Swanson KV, Deng M and Ting JP: The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nat Rev Immunol. 19:477–489. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lu A and Wu H: Structural mechanisms of inflammasome assembly. FEBS J. 282:435–444. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Stutz A, Kolbe CC, Stahl R, Horvath GL, Franklin BS, van Ray O, Brinkschulte R, Geyer M, Meissner F and Latz E: NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain. J Exp Med. 214:1725–1736. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SR, Lee SG, Kim SH, Kim JH, Choi E, Cho W, Rim JH, Hwang I, Lee CJ, Lee M, et al: SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease. Nat Commun. 11:21272020. View Article : Google Scholar : PubMed/NCBI | |
|
Tumurkhuu G, Shimada K, Dagvadorj J, Crother TR, Zhang W, Luthringer D, Gottlieb RA, Chen S and Arditi M: Ogg1-Dependent DNA Repair Regulates NLRP3 Inflammasome and Prevents Atherosclerosis. Circ Res. 119:e76–e90. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Renaudin F, Orliaguet L, Castelli F, Fenaille F, Prignon A, Alzaid F, Combes C, Delvaux A, Adimy Y, Cohen-Solal M, et al: Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages. Ann Rheum Dis. 79:1506–1514. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Afonina IS, Zhong Z, Karin M and Beyaert R: Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome. Nat Immunol. 18:861–869. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
He Y, Hara H and Núñez G: Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 41:1012–1021. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Karmakar M, Katsnelson M, Malak HA, Greene NG, Howell SJ, Hise AG, Camilli A, Kadioglu A, Dubyak GR and Pearlman E: Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux. J Immunol. 194:1763–1775. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Di A, Xiong S, Ye Z, Malireddi RKS, Kometani S, Zhong M, Mittal M, Hong Z, Kanneganti T-D, Rehman J, et al: The TWIK2 potassium efflux channel in macrophages mediates NLRP3 inflammasome-induced inflammation. Immunity. 49:56–65.e4. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Gianfrancesco MA, Dehairs J, L'homme L, Herinckx G, Esser N, Jansen O, Habraken Y, Lassence C, Swinnen JV, Rider MH, et al: Saturated fatty acids induce NLRP3 activation in human macrophages through K+ efflux resulting from phospholipid saturation and Na, K-ATPase disruption. Biochim Biophys Acta Mol Cell Biol Lipids. 1864:1017–1030. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Hu D, Feng Y, Wu C, Song Y, Liu W, Li A, Wang Y, Chen K, Tian M, et al: Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome. BMC Biol. 18:1822020. View Article : Google Scholar : PubMed/NCBI | |
|
Rühl S and Broz P: Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux. Eur J Immunol. 45:2927–2936. 2015. View Article : Google Scholar | |
|
Katsnelson MA, Rucker LG, Russo HM and Dubyak GR: K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling. J Immunol. 194:3937–3952. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Abais JM, Xia M, Zhang Y, Boini KM and Li PL: Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxid Redox Signal. 22:1111–1129. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang C, Abdukerim M, Abilailieti M, Tang L, Ling Y and Pan S: The protective effects of orexin a against high glucose-induced activation of NLRP3 inflammasome in human vascular endothelial cells. Arch Biochem Biophys. 672:1080522019. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao H, Lu M, Lin TY, Chen Z, Chen G, Wang W-C, Marin T, Shentu TP, Wen L, Gongol B, et al: Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation. 128:632–642. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Rada B, Park JJ, Sil P, Geiszt M and Leto TL: NLRP3 inflammasome activation and interleukin-1β release in macrophages require calcium but are independent of calcium-activated NADPH oxidases. Inflamm Res. 63:821–830. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Han Y, Xu X, Tang C, Gao P, Chen X, Xiong X, Yang M, Yang S, Zhu X, Yuan S, et al: Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis. Redox Biol. 16:32–46. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, et al: Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 36:401–414. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhong B, Liu X, Wang X, Liu X, Li H, Darnay BG, Lin X, Sun SC and Dong C: Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3. Sci Signal. 6:ra352013. View Article : Google Scholar : PubMed/NCBI | |
|
Lee HE, Yang G, Park YB, Kang HC, Cho YY, Lee HS and Lee JY: Epigallocatechin-3-gallate prevents acute gout by suppressing NLRP3 inflammasome activation and mitochondrial DNA synthesis. Molecules. 24:21382019. View Article : Google Scholar : PubMed/NCBI | |
|
Park S, Juliana C, Hong S, Datta P, Hwang I, Fernandes-Alnemri T, Yu JW and Alnemri ES: The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity. J Immunol. 191:4358–4366. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Subramanian N, Natarajan K, Clatworthy MR, Wang Z and Germain RN: The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell. 153:348–361. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Zhang S, Li F and Qin L: NLRX1 attenuates apoptosis and inflammatory responses in myocardial ischemia by inhibiting MAVS-dependent NLRP3 inflammasome activation. Mol Immunol. 76:90–97. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Iyer SS, He Q, Janczy JR, Elliott EI, Zhong Z, Olivier AK, Sadler JJ, Knepper-Adrian V, Han R, Qiao L, et al: Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity. 39:311–323. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Elliott EI, Miller AN, Banoth B, Iyer SS, Stotland A, Weiss JP, Gottlieb RA, Sutterwala FS and Cassel SL: Cutting edge: Mitochondrial assembly of the NLRP3 inflammasome complex is initiated at priming. J Immunol. 200:3047–3052. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ichinohe T, Yamazaki T, Koshiba T and Yanagi Y: Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc Natl Acad Sci USA. 110:17963–17968. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen J and Chen ZJ: PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation. Nature. 564:71–76. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Meszaros G, He WT, Xu Y, de Fatima Magliarelli H, Mailly L, Mihlan M, Liu Y, Puig Gámez M, Goginashvili A, et al: Protein kinase D at the Golgi controls NLRP3 inflammasome activation. J Exp Med. 214:2671–2693. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Riteau N, Baron L, Villeret B, Guillou N, Savigny F, Ryffel B, Rassendren F, Le Bert M, Gombault A and Couillin I: ATP release and purinergic signaling: A common pathway for particle-mediated inflammasome activation. Cell Death Dis. 3:e4032012. View Article : Google Scholar : PubMed/NCBI | |
|
Jessop F, Hamilton RF Jr, Rhoderick JF, Fletcher P and Holian A: Phagolysosome acidification is required for silica and engineered nanoparticle-induced lysosome membrane permeabilization and resultant NLRP3 inflammasome activity. Toxicol Appl Pharmacol. 318:58–68. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Heid ME, Keyel PA, Kamga C, Shiva S, Watkins SC and Salter RD: Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J Immunol. 191:5230–5238. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Liu A, Gao X, Zhang Q and Cui L: Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway. Mol Med Rep. 8:361–366. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Newman ZL, Leppla SH and Moayeri M: CA-074Me protection against anthrax lethal toxin. Infect Immun. 77:4327–4336. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Orlowski GM, Colbert JD, Sharma S, Bogyo M, Robertson SA and Rock KL: Multiple cathepsins promote Pro-IL-1β synthesis and NLRP3-mediated IL-1β activation. J Immunol. 195:1685–1697. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chevriaux A, Pilot T, Derangère V, Simonin H, Martine P, Chalmin F, Ghiringhelli F and Rébé C: Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction. Front Cell Dev Biol. 8:1672020. View Article : Google Scholar : PubMed/NCBI | |
|
Tang TT, Lv LL, Pan MM, Wen Y, Wang B, Li ZL, Wu M, Wang FM, Crowley SD and Liu BC: Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation. Cell Death Dis. 9:3512018. View Article : Google Scholar : PubMed/NCBI | |
|
Bai H, Yang B, Yu W, Xiao Y, Yu D and Zhang Q: Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome. Exp Cell Res. 362:180–187. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang D, Bu F and Zhang W: The role of ubiquitination in regulating embryonic stem cell maintenance and cancer development. Int J Mol Sci. 20:26672019. View Article : Google Scholar : PubMed/NCBI | |
|
Song H, Liu B, Huai W, Yu Z, Wang W, Zhao J, Han L, Jiang G, Zhang L, Gao C, et al: The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat Commun. 7:137272016. View Article : Google Scholar : PubMed/NCBI | |
|
Singh M, Kumari B and Yadav UCS: Regulation of oxidized LDL-induced inflammatory process through NLRP3 inflammasome activation by the deubiquitinating enzyme BRCC36. Inflamm Res. 68:999–1010. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhuo Y, Li D, Cui L, Li C, Zhang S, Zhang Q, Zhang L, Wang X and Yang L: Treatment with 3,4-dihydroxyphenylethyl alcohol glycoside ameliorates sepsis-induced ALI in mice by reducing inflammation and regulating M1 polarization. Biomed Pharmacother. 116:1090122019. View Article : Google Scholar : PubMed/NCBI | |
|
Kawashima A, Karasawa T, Tago K, Kimura H, Kamata R, Usui-Kawanishi F, Watanabe S, Ohta S, Funakoshi-Tago M, Yanagisawa K, et al: ARIH2 ubiquitinates NLRP3 and negatively regulates NLRP3 inflammasome activation in macrophages. J Immunol. 199:3614–3622. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Humphries F, Bergin R, Jackson R, Delagic N, Wang B, Yang S, Dubois AV, Ingram RJ and Moynagh PN: The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome. Nat Commun. 9:15602018. View Article : Google Scholar : PubMed/NCBI | |
|
Xing Y, Yao X, Li H, Xue G, Guo Q, Yang G, An L, Zhang Y and Meng G: Cutting edge: TRAF6 mediates TLR/IL-1R signaling-induced nontranscriptional priming of the NLRP3 inflammasome. J Immunol. 199:1561–1566. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Weng L, Mitoma H, Trichot C, Bao M, Liu Y, Zhang Z and Liu YJ: The E3 ubiquitin ligase tripartite motif 33 is essential for cytosolic RNA-induced NLRP3 inflammasome activation. J Immunol. 193:3676–3682. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Guan K, Wei C, Zheng Z, Song T, Wu F, Zhang Y, Cao Y, Ma S, Chen W, Xu Q, et al: MAVS promotes inflammasome activation by targeting ASC for K63-linked ubiquitination via the E3 ligase TRAF3. J Immunol. 194:4880–4890. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chiu HW, Chen CH, Chang JN, Chen CH and Hsu YH: Far-infrared promotes burn wound healing by suppressing NLRP3 inflammasome caused by enhanced autophagy. J Mol Med (Berl). 94:809–819. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Rodgers MA, Bowman JW, Fujita H, Orazio N, Shi M, Liang Q, Amatya R, Kelly TJ, Iwai K, Ting J, et al: The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. J Exp Med. 211:1333–1347. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Labbé K, McIntire CR, Doiron K, Leblanc PM and Saleh M: Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. Immunity. 35:897–907. 2011. View Article : Google Scholar | |
|
Vince JE, Wong WW-L, Gentle I, Lawlor KE, Allam R, O'Reilly L, Mason K, Gross O, Ma S, Guarda G, et al: Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity. 36:215–227. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Basak C, Pathak SK, Bhattacharyya A, Mandal D, Pathak S and Kundu M: NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages. J Biol Chem. 280:4279–4288. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Li C-G, Yan L, Mai F-Y, Shi Z-J, Xu L-H, Jing Y-Y, Zha Q-B, Ouyang D-Y and He X-H: Baicalin inhibits NOD-like receptor family, pyrin containing domain 3 inflammasome activation in murine macrophages by augmenting protein kinase A signaling. Front Immunol. 8:14092017. View Article : Google Scholar : PubMed/NCBI | |
|
Guo C, Xie S, Chi Z, Zhang J, Liu Y, Zhang L, Zheng M, Zhang X, Xia D, Ke Y, et al: Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity. 45:802–816. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Spalinger MR, Kasper S, Gottier C, Lang S, Atrott K, Vavricka SR, Scharl S, Raselli T, Frey-Wagner I, Gutte PM, et al: NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22. J Clin Invest. 126:1783–1800. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Martin BN, Wang C, Willette-Brown J, Herjan T, Gulen MF, Zhou H, Bulek K, Franchi L, Sato T, Alnemri ES, et al: IKKα negatively regulates ASC-dependent inflammasome activation. Nat Commun. 5:49772014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou R, Yang X, Li X, Qu Y, Huang Q, Sun X and Mu D: Recombinant CC16 inhibits NLRP3/caspase-1-induced pyroptosis through p38 MAPK and ERK signaling pathways in the brain of a neonatal rat model with sepsis. J Neuroinflammation. 16:2392019. View Article : Google Scholar : PubMed/NCBI | |
|
Fu Q, Wu J, Zhou XY, Ji MH, Mao QH, Li Q, Zong MM, Zhou ZQ and Yang JJ: NLRP3/Caspase-1 Pathway-induced pyroptosis mediated cognitive deficits in a mouse model of sepsis-associated encephalopathy. Inflammation. 42:306–318. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xu G, Shi D, Zhi Z, Ao R and Yu B: Melatonin ameliorates spinal cord injury by suppressing the activation of inflammasomes in rats. J Cell Biochem. 120:5183–5192. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Cao S, Shrestha S, Li J, Yu X, Chen J, Yan F, Ying G, Gu C, Wang L and Chen G: Melatonin-mediated mitophagy protects against early brain injury after subarachnoid hemorrhage through inhibition of NLRP3 inflammasome activation. Sci Rep. 7:24172017. View Article : Google Scholar : PubMed/NCBI | |
|
Tong Z, Jiang B, Zhang L, Liu Y, Gao M, Jiang Y, Li Y, Lu Q, Yao Y and Xiao X: HSF-1 is involved in attenuating the release of inflammatory cytokines induced by LPS through regulating autophagy. Shock. 41:449–453. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang W, Tao A, Lan T, Cepinskas G, Kao R, Martin CM and Rui T: Carbon monoxide releasing molecule-3 improves myocardial function in mice with sepsis by inhibiting NLRP3 inflammasome activation in cardiac fibroblasts. Basic Res Cardiol. 112:162017. View Article : Google Scholar : PubMed/NCBI | |
|
Tanuseputero SA, Lin MT, Yeh SL and Yeh CL: Intravenous arginine administration downregulates NLRP3 inflammasome activity and attenuates acute kidney injury in mice with polymicrobial sepsis. Mediators Inflamm. 2020:32016352020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang YC, Liu QX, Zheng Q, Liu T, Xu XE, Liu XH, Gao W, Bai XJ and Li ZF: Dihydromyricetin alleviates sepsis-induced acute lung injury through inhibiting NLRP3 inflammasome-dependent pyroptosis in mice model. Inflammation. 42:1301–1310. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lyubasyuk V, Ouyang H, Yu FX, Guan KL and Zhang K: YAP inhibition blocks uveal melanogenesis driven by GNAQ or GNA11 mutations. Mol Cell Oncol. 2:e9709572014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Zhang CY, Duan JX, Li Q, Yang HH, Sun CC, Zhang J, Luo XQ and Liu SK: Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages. Biomed Pharmacother. 121:1095962020. View Article : Google Scholar : PubMed/NCBI | |
|
Ying Y, Mao Y and Yao M: NLRP3 inflammasome activation by microRNA-495 promoter methylation may contribute to the progression of acute lung injury. Mol Ther Nucleic Acids. 18:801–814. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Mosoian A, Schwartz ME, Florman SS, Gunasekaran G, Schiano T, Fiel MI, Jiang W, Shen Q, Branch AD, et al: HIV infection modulates IL-1β response to LPS stimulation through a TLR4-NLRP3 pathway in human liver macrophages. J Leukoc Biol. 105:783–795. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Liu G, Yuan Y, Wu G, Wang S and Yuan L: NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling. Cell Death Dis. 10:9062019. View Article : Google Scholar : PubMed/NCBI | |
|
Bai RX, Xu YY, Qin G, Chen YM, Wang HF, Wang M and Du SY: Repression of TXNIP-NLRP3 axis restores intestinal barrier function via inhibition of myeloperoxidase activity and oxidative stress in nonalcoholic steatohepatitis. J Cell Physiol. 234:7524–7538. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Han J, Bae J, Choi CY, Choi SP, Kang HS, Jo EK, Park J, Lee YS, Moon HS, Park CG, et al: Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via inhibition of NLRP3 inflammasome activation in mice. Autophagy. 12:2326–2343. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yang M, Lu L, Kang Z, Ma T and Wang Y: Overexpressed CD39 mitigates sepsis-induced kidney epithelial cell injury via suppressing the activation of NLR family pyrin domain containing 3. Int J Mol Med. 44:1707–1718. 2019.PubMed/NCBI | |
|
Chen Y, Jin S, Teng X, Hu Z, Zhang Z, Qiu X, Tian D and Wu Y: Hydrogen sulfide attenuates LPS-induced acute kidney injury by inhibiting inflammation and oxidative stress. Oxid Med Cell Longev. 2018:67172122018. View Article : Google Scholar : PubMed/NCBI | |
|
Yao Y, Hu X, Feng X, Zhao Y, Song M, Wang C and Fan H: Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway. J Cell Biochem. 120:18509–18523. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Cornelius DC, Travis OK, Tramel RW, Borges-Rodriguez M, Baik CH, Greer M, Giachelli CA, Tardo GA and Williams JM: NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture. PLoS One. 15:e02340392020. View Article : Google Scholar : PubMed/NCBI | |
|
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 315:801–810. 2016. View Article : Google Scholar : PubMed/NCBI |
